Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG1885

LAMB1 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

LAMB1 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population in the Raji B lymphoblastoid cell line, disrupting the LAMB1 gene encoding laminin ??1. This model impairs integrin-mediated adhesion and signaling downstream of regulators such as TGFB1 and effectors including FAK and AKT, offering a system to study B cell migration, lymphocyte homing, and basement membrane biology. Applications include investigating cancer cell invasion, ECM remodeling in lymphoma, and drug targeting of laminin?Cintegrin interactions, with assays such as adhesion and migration assays, flow cytometry, and phospho-signaling analysis.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    LAMB1

    Gene Identifier

    NCBI Gene ID 3912

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

LAMB1 Knockout Raji Polyclonal Cells represent a CRISPR/Cas9-mediated polyclonal knockout population in the Raji B lymphoblastoid cell line, designed to disrupt expression of the LAMB1 gene. This loss-of-function model enables investigation of laminin ??1 subunit function in a B lymphocyte context. The polyclonal format provides a heterogeneous pool of edited cells, suitable for studying gene disruption effects without clonal isolation.

The Raji cell line, derived from a Burkitt lymphoma, is an Epstein?CBarr virus (EBV)-positive lymphoblastoid cell line widely used as a model for B cell biology, antigen presentation, and antibody production. These suspension-adapted cells maintain key characteristics of mature B lymphocytes and serve as a robust platform for functional genomics studies. Their lymphoblastoid origin makes them particularly relevant for exploring signaling networks and adhesion mechanisms governing B cell behavior.

LAMB1 encodes the laminin ??1 subunit, a critical component of laminin-111 (??1??1??1) and other heterotrimeric basement membrane glycoproteins. Through interactions with integrin receptors such as ??6??1 and ??3??1, dystroglycan, and nidogen, LAMB1 mediates cell adhesion, migration, and matrix assembly. Expression of LAMB1 is regulated by growth factors including TGFB1, EGF, HGF, and FGF2, and transcription factors AP-1 and STAT3. Downstream, laminin engagement activates focal adhesion kinase (FAK) and SRC, leading to phosphorylation of AKT and MAPK1/3, and ultimately influencing cytoskeletal reorganization via RAC1 and RHOA. Thus, LAMB1 integrates extracellular signals to control PI3K/Akt and MAPK/ERK pathways, as well as focal adhesion dynamics.

In the context of Raji B cells, LAMB1 knockout disrupts integrin-mediated adhesion and signaling, potentially impairing cell migration and lymphocyte homing. Given the role of laminins in lymphoid tissue organization and immune cell trafficking, this model provides a tool to dissect how B cells interact with basement membranes and extracellular matrix. Disruption of LAMB1 may alter the ability of these lymphoma-derived cells to invade tissues, offering insights into cancer metastasis and the mechanisms underlying ECM remodeling in lymphomagenesis. Moreover, the model can be used to study the contribution of laminin?Cintegrin interactions to B cell activation and differentiation.

This polyclonal knockout cell population is suitable for a range of research applications, including the study of B cell migration and adhesion, basement membrane biology, and lymphocyte homing. It enables investigation of drug targeting of integrin?Claminin interactions and ECM remodeling in lymphoma. Typical assays include western blotting for LAMB1, RT-qPCR, flow cytometry for integrin expression, cell adhesion and migration assays, immunofluorescence for laminin organization, phospho-signaling analysis of FAK and AKT, and co-immunoprecipitation of laminin complexes. For additional technical details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)